Clinical Trials Browser

Phase 4 × UNKNOWN × toripalimab × Clear all

NCT05291910 2022-03-23

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

Phase 4 Unknown

Breast Neoplasms